A polygenic risk score for multiple myeloma risk prediction
dc.contributor.author | Canzian, Federico | |
dc.contributor.author | Piredda, Chiara | |
dc.contributor.author | Macauda, Angelica | |
dc.contributor.author | Zawirska, Daria | |
dc.contributor.author | Andersen, Niels Frost | |
dc.contributor.author | Nagler, Arnon | |
dc.contributor.author | Zaucha, Jan Maciej | |
dc.contributor.author | Mazur, Grzegorz | |
dc.contributor.author | Dumontet, Charles | |
dc.contributor.author | Watek, Marzena | |
dc.contributor.author | Jamroziak, Krzysztof | |
dc.contributor.author | Sainz, Juan | |
dc.contributor.author | Varkonyi, Judit | |
dc.contributor.author | Butrym, Aleksandra | |
dc.contributor.author | Beider, Katia | |
dc.contributor.author | Abildgaard, Niels | |
dc.contributor.author | Lesueur, Fabienne | |
dc.contributor.author | Dudzinski, Marek | |
dc.contributor.author | Vangsted, Annette Juul | |
dc.contributor.author | Pelosini, Matteo | |
dc.contributor.author | Subocz, Edyta | |
dc.contributor.author | Petrini, Mario | |
dc.contributor.author | Buda, Gabriele | |
dc.contributor.author | Razny, Malgorzata | |
dc.contributor.author | Gemignani, Federica | |
dc.contributor.author | Marques, Herlander | |
dc.contributor.author | Orciuolo, Enrico | |
dc.contributor.author | Kadar, Katalin | |
dc.contributor.author | Jurczyszyn, Artur | |
dc.contributor.author | Druzd-Sitek, Agnieszka | |
dc.contributor.author | Vogel, Ulla | |
dc.contributor.author | Andersen, Vibeke | |
dc.contributor.author | Reis, Rui Manuel | |
dc.contributor.author | Suska, Anna | |
dc.contributor.author | Avet-Loiseau, Herve | |
dc.contributor.author | Kruszewski, Marcin | |
dc.contributor.author | Tomczak, Waldemar | |
dc.contributor.author | Rymko, Marcin | |
dc.contributor.author | Minvielle, Stephane | |
dc.contributor.author | Campa, Daniele | |
dc.contributor.authoraffiliation | [Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany | |
dc.contributor.authoraffiliation | [Piredda, Chiara] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany | |
dc.contributor.authoraffiliation | [Macauda, Angelica] German Canc Res Ctr, Genom Epidemiol Grp, Heidelberg, Germany | |
dc.contributor.authoraffiliation | [Piredda, Chiara] Univ Pisa, Dept Biol, Pisa, Italy | |
dc.contributor.authoraffiliation | [Macauda, Angelica] Univ Pisa, Dept Biol, Pisa, Italy | |
dc.contributor.authoraffiliation | [Gemignani, Federica] Univ Pisa, Dept Biol, Pisa, Italy | |
dc.contributor.authoraffiliation | [Campa, Daniele] Univ Pisa, Dept Biol, Pisa, Italy | |
dc.contributor.authoraffiliation | [Zawirska, Daria] Univ Hosp Cracow, Dept Hematol, Krakow, Poland | |
dc.contributor.authoraffiliation | [Andersen, Niels Frost] Aarhus Univ Hosp, Dept Hematol, Aarhus, Denmark | |
dc.contributor.authoraffiliation | [Nagler, Arnon] Chaim Sheba Med Ctr, Hematol Div, Tel Hashomer, Israel | |
dc.contributor.authoraffiliation | [Beider, Katia] Chaim Sheba Med Ctr, Hematol Div, Tel Hashomer, Israel | |
dc.contributor.authoraffiliation | [Zaucha, Jan Maciej] Sea Hosp, Dept Hematol, Gdynia, Poland | |
dc.contributor.authoraffiliation | [Mazur, Grzegorz] Med Univ Wroclaw, Dept Internal & Occupat Dis Hypertens & Clin Onco, Wroclaw, Poland | |
dc.contributor.authoraffiliation | [Dumontet, Charles] Hosp Civils Lyon, Canc Res Ctr Lyon, Lyon, France | |
dc.contributor.authoraffiliation | [Watek, Marzena] Holycross Canc Ctr, Hematol Clin, Kielce, Poland | |
dc.contributor.authoraffiliation | [Jamroziak, Krzysztof] Inst Hematol & Transfus Med, Dept Hematol, Warsaw, Poland | |
dc.contributor.authoraffiliation | [Sainz, Juan] Univ Granada, GENYO Ctr Genom & Oncol Res Pfizer, Genom Oncol Area, Andalusian Reg Govt, Granada, Spain | |
dc.contributor.authoraffiliation | [Sainz, Juan] Virgen de las Nieves Univ Hosp, Hematol Dept, Granada, Spain | |
dc.contributor.authoraffiliation | [Varkonyi, Judit] Semmelweis Univ, Dept Internal Med 3, Budapest, Hungary | |
dc.contributor.authoraffiliation | [Kadar, Katalin] Semmelweis Univ, Dept Internal Med 3, Budapest, Hungary | |
dc.contributor.authoraffiliation | [Butrym, Aleksandra] Med Univ Wroclaw, Dept Internal & Occupat Dis, Wroclaw, Poland | |
dc.contributor.authoraffiliation | [Abildgaard, Niels] Odense Univ Hosp, Dept Hematol, Odense, Denmark | |
dc.contributor.authoraffiliation | [Lesueur, Fabienne] PSL Res Univ, Inst Curie, U900, Mines ParisTech Inserm, Paris, France | |
dc.contributor.authoraffiliation | [Dudzinski, Marek] Teaching Hosp 1, Hematol Dept, Rzeszow, Poland | |
dc.contributor.authoraffiliation | [Vangsted, Annette Juul] Univ Copenhagen, Rigshosp, Dept Hematol, Copenhagen, Denmark | |
dc.contributor.authoraffiliation | [Pelosini, Matteo] Univ Pisa, Sect Hematol, Clin & Expt Med, Pisa, Italy | |
dc.contributor.authoraffiliation | [Petrini, Mario] Univ Pisa, Sect Hematol, Clin & Expt Med, Pisa, Italy | |
dc.contributor.authoraffiliation | [Buda, Gabriele] Univ Pisa, Sect Hematol, Clin & Expt Med, Pisa, Italy | |
dc.contributor.authoraffiliation | [Orciuolo, Enrico] Univ Pisa, Sect Hematol, Clin & Expt Med, Pisa, Italy | |
dc.contributor.authoraffiliation | [Subocz, Edyta] Mil Inst Med, Dept Haematol, Warsaw, Poland | |
dc.contributor.authoraffiliation | [Razny, Malgorzata] Rydygier Specialist Hosp, Dept Hematol, Krakow, Poland | |
dc.contributor.authoraffiliation | [Marques, Herlander] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Mol Oncol Res Ctr, Braga, Portugal | |
dc.contributor.authoraffiliation | [Reis, Rui Manuel] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Mol Oncol Res Ctr, Braga, Portugal | |
dc.contributor.authoraffiliation | [Jurczyszyn, Artur] Jagiellonian Univ Med Coll, Dept Hematol, Krakow, Poland | |
dc.contributor.authoraffiliation | [Suska, Anna] Jagiellonian Univ Med Coll, Dept Hematol, Krakow, Poland | |
dc.contributor.authoraffiliation | [Druzd-Sitek, Agnieszka] Maria Sklodowska Curie Natl Res Inst Oncol, Warsaw, Poland | |
dc.contributor.authoraffiliation | [Vogel, Ulla] Natl Res Ctr Working Environm, DK-2100 Copenhagen, Denmark | |
dc.contributor.authoraffiliation | [Andersen, Vibeke] Univ Southern Denmark, Inst Mol Med, Odense, Denmark | |
dc.contributor.authoraffiliation | [Reis, Rui Manuel] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal | |
dc.contributor.authoraffiliation | [Reis, Rui Manuel] Barretos Canc Hosp, Mol Oncol Res Ctr, Sao Paulo, Brazil | |
dc.contributor.authoraffiliation | [Avet-Loiseau, Herve] Inst Univ Canc Toulouse Oncopole, Unite Genom Myelome, Toulouse, France | |
dc.contributor.authoraffiliation | [Kruszewski, Marcin] Univ Hosp Bydgoszcz, Dept Hematol, Bydgoszcz, Poland | |
dc.contributor.authoraffiliation | [Tomczak, Waldemar] Med Univ Lublin, Lublin, Poland | |
dc.contributor.authoraffiliation | [Rymko, Marcin] N Copernicus Town Hosp, Dept Hematol, Torun, Poland | |
dc.contributor.authoraffiliation | [Minvielle, Stephane] Univ Nantes, Univ Angers, CNRS, INSERM,CRCINA, Nantes, France | |
dc.contributor.funder | University of Pisa, DKFZ | |
dc.contributor.funder | University Hospital of Southern Jutland, Denmark | |
dc.contributor.funder | French National Cancer Institute (INCA) | |
dc.date.accessioned | 2025-01-07T14:24:50Z | |
dc.date.available | 2025-01-07T14:24:50Z | |
dc.date.issued | 2021-11-30 | |
dc.description.abstract | There is overwhelming epidemiologic evidence that the risk of multiple myeloma (MM) has a solid genetic background. Genome-wide association studies (GWAS) have identified 23 risk loci that contribute to the genetic susceptibility of MM, but have low individual penetrance. Combining the SNPs in a polygenic risk score (PRS) is a possible approach to improve their usefulness. Using 2361 MM cases and 1415 controls from the International Multiple Myeloma rESEarch (IMMEnSE) consortium, we computed a weighted and an unweighted PRS. We observed associations with MM risk with OR = 3.44, 95% CI 2.53-4.69, p = 3.55 x 10(-15) for the highest vs. lowest quintile of the weighted score, and OR = 3.18, 95% CI 2.1 = 34-4.33, p = 1.62 x 10(-13) for the highest vs. lowest quintile of the unweighted score. We found a convincing association of a PRS generated with 23 SNPs and risk of MM. Our work provides additional validation of previously discovered MM risk variants and of their combination into a PRS, which is a first step towards the use of genetics for risk stratification in the general population. | |
dc.identifier.doi | 10.1038/s41431-021-00986-8 | |
dc.identifier.essn | 1476-5438 | |
dc.identifier.issn | 1018-4813 | |
dc.identifier.pmid | 34845334 | |
dc.identifier.unpaywallURL | https://www.nature.com/articles/s41431-021-00986-8.pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/26366 | |
dc.identifier.wosID | 723492300001 | |
dc.issue.number | 4 | |
dc.journal.title | European journal of human genetics | |
dc.journal.titleabbreviation | Eur. j. hum. genet. | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Virgen de las Nieves | |
dc.organization | Centro Pfizer-Andalucía de Genómica e Investigación Oncológica (GENYO) | |
dc.page.number | 474-479 | |
dc.publisher | Springernature | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Monoclonal gammopathy | |
dc.subject | Stratification | |
dc.subject | Polymorphisms | |
dc.subject | Epidemiology | |
dc.title | A polygenic risk score for multiple myeloma risk prediction | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 30 | |
dc.wostype | Article |